Patient Enrollment In Oncology Clinical Trials Challenges & Best Solutions
Patient enrollment has always been a challenge in clinical trials, in general and it is more so in oncology clinical trials. Oncology clinical trials take longer time than other therapeutic areas primarily due to delays in patient enrollment. In US, the adult participation in cancer clinical trials remains around 3% with even lower participation rates among ethnic, racial minorities and elderly people. Sponsors/CROs and sites increasingly struggle to reach enrollment targets due to a variety of reasons including nature of disease itself. However, understanding, analyzing these challenges & barriers in patient enrollment in oncology trials and addressing them with thoughtful, strategic, result-oriented plans & procedures is the key to success.
This webinar will cover
- Understanding challenges around patient enrollment in oncology clinical trials
- Key policies and procedures that sites can do to enhance enrollment in oncology CTs
- Practical approaches for community engagement in oncology CTs
From your own Desk (minimum requirement: Internet connection & Speaker / head set).
MakroCare is an international drug development and commercialization services firm that is dedicated to efficient, high-level performance in combination with unparalleled client satisfaction supporting from USA, Europe and Asia. MakroCare has 5 subsidiaries/divisions – Consulting, CRO, SMO, DDi and Commercialization. MakroCare has teams positioned worldwide in these divisions supporting product life cycle management, regulatory affairs, risk management, regulatory compliance, trial management (clinical, late phase), monitoring, biometrics (CDM, EDC, Biostat, SAS programming), Medical Writing (Regulatory, Clinical), QA audits, Drug safety / Pharmacovigilance, Site management, Patient Recruitment, Informatics (EDC, CTMS, IVRS), Commercialization, and Marketing/Sales.